LDVP_apexigen_featured

Apexigen, Inc. is a clinical-stage biopharmaceutical company discovering and developing the next generation of antibody therapeutics for the treatment of cancer with an emphasis on new immuno-oncology products that harness the patient’s immune system to combat and eradicate cancer.

CEO: Xiaodong Yang, MD, Ph.D.

Status: Private

Company Headquarters: San Carlos, CA

www.apexigen.com